{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T17:56:29Z","timestamp":1767462989144,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"DOI":"10.7759\/cureus.100700","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T17:52:29Z","timestamp":1767462749000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperleukocytosis in a Patient With Chronic Myeloid Leukemia and HIV: A Case Report"],"prefix":"10.7759","author":[{"given":"Javier B","family":"Chambi-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Penate Armesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temilola O","family":"Majekodunmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohair","family":"Angly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1073-2","article-title":"Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection","volume":"95","author":"Webb MJ","year":"2012","unstructured":"Webb MJ, Barrett CL, Pretorius C, van Jaarsveld MF, Louw VJ. Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection. Int J Hematol. 2012, 95:556-63. 10.1007\/s12185-012-1073-2","journal-title":"Int J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.07.012","article-title":"Human immunodeficiency virus infection and chronic myeloid leukemia","volume":"36","author":"Patel M","year":"2012","unstructured":"Patel M, Philip V, Fazel F, et al.. Human immunodeficiency virus infection and chronic myeloid leukemia. Leuk Res. 2012, 36:1334-8. 10.1016\/j.leukres.2012.07.012","journal-title":"Leuk Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels MS","year":"2018","unstructured":"Shiels MS, Islam JY, Rosenberg PS, Hall HI, Jacobson E, Engels EA. Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030. Ann Intern Med. 2018, 168:866-73. 10.7326\/M17-2499","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-164740","article-title":"Viral infections and reactivations in chronic myeloid leukemia patients on tyrosine kinase inhibitors (TKIs)","volume":"140","author":"Aldapt MB","year":"2022","unstructured":"Aldapt MB, Obeidat K, Yassin MA. Viral infections and reactivations in chronic myeloid leukemia patients on tyrosine kinase inhibitors (TKIs). Blood. 2022, 140:12223-4. 10.1182\/blood-2022-164740","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1270754","article-title":"Hyperleukocytosis and leukostasis: management of a medical emergency","volume":"10","author":"Giammarco S","year":"2017","unstructured":"Giammarco S, Chiusolo P, Piccirillo N, et al.. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol. 2017, 10:147-54. 10.1080\/17474086.2017.1270754","journal-title":"Expert Rev Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14740\/jh1150","article-title":"Leukostasis with isolated central nervous system involvement in chronic phase of chronic myelogenous leukemia","volume":"12","author":"Jeon WJ","year":"2023","unstructured":"Jeon WJ, Dalal S, Moon JH, et al.. Leukostasis with isolated central nervous system involvement in chronic phase of chronic myelogenous leukemia. J Hematol. 2023, 12:187-96. 10.14740\/jh1150","journal-title":"J Hematol"},{"key":"ref7","article-title":"Clinical manifestations and diagnosis of chronic myeloid leukemia","author":"Van Etten R","year":"2025","unstructured":"Van Etten R, Atallah E. Clinical manifestations and diagnosis of chronic myeloid leukemia. UpToDate. Connor RF (ed): Wolters Kluwer, 2025."},{"key":"ref8","article-title":"Hyperleukocytosis and leukostasis in hematologic malignancies","year":"2024","unstructured":"Hyperleukocytosis and leukostasis in hematologic malignancies. Connor RF (ed). Wolters Kluwer, 2024."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour E","year":"2020","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020, 95:691-709. 10.1002\/ajh.25792","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.043166","article-title":"Rapid diagnosis of chronic myeloid leukemia by flow cytometric detection of BCR-ABL1 protein","volume":"96","author":"Lucas CM","year":"2011","unstructured":"Lucas CM, Fagan JL, Carter A, Swale B, Evans C, Clark RE, Harris RJ. Rapid diagnosis of chronic myeloid leukemia by flow cytometric detection of BCR-ABL1 protein. Haematologica. 2011, 96:1077-8. 10.3324\/haematol.2011.043166","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini M","year":"2013","unstructured":"Paiardini M, M\u00fcller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013, 254:78-101. 10.1111\/imr.12079","journal-title":"Immunol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802074601","article-title":"Chronic myeloid leukemia and HIV-infection","volume":"49","author":"Schlaberg R","year":"2008","unstructured":"Schlaberg R, Fisher JG, Flamm MJ, Murty VV, Bhagat G, Alobeid B. Chronic myeloid leukemia and HIV-infection. Leuk Lymphoma. 2008, 49:1155-60. 10.1080\/10428190802074601","journal-title":"Leuk Lymphoma"},{"key":"ref14","article-title":"Hydroxyurea toxicity","author":"Jinna S","year":"2024","unstructured":"Jinna S, Khandhar PB. Hydroxyurea toxicity. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2056178","article-title":"Hyperleukocytosis and leukostasis in acute and chronic leukemias","volume":"63","author":"Macaron W","year":"2022","unstructured":"Macaron W, Sargsyan Z, Short NJ. Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leuk Lymphoma. 2022, 63:1780-91. 10.1080\/10428194.2022.2056178","journal-title":"Leuk Lymphoma"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70579-5","article-title":"Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective","volume":"15","author":"van Leeuwen RWF","year":"2014","unstructured":"van Leeuwen RWF, van Gelder T, Mathijssen RHJ, Jansman FGA. Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective. Lancet Oncol. 2014, 15:315-26. 10.1016\/S1470-2045(13)70579-5","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3413-7","article-title":"Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?","volume":"97","author":"Osorio S","year":"2018","unstructured":"Osorio S, Escudero-Vilaplana V, G\u00f3mez-Centuri\u00f3n I, et al.. Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?. Ann Hematol. 2018, 97:2089-98. 10.1007\/s00277-018-3413-7","journal-title":"Ann Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030917","article-title":"Immunomodulatory activity of the tyrosine kinase inhibitor dasatinib to elicit NK cytotoxicity against cancer, HIV infection and aging","volume":"15","author":"Rodr\u00edguez-Agust\u00edn A","year":"2023","unstructured":"Rodr\u00edguez-Agust\u00edn A, Casanova V, Grau-Exp\u00f3sito J, S\u00e1nchez-Palomino S, Alcam\u00ed J, Climent N. Immunomodulatory activity of the tyrosine kinase inhibitor dasatinib to elicit NK cytotoxicity against cancer, HIV infection and aging. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15030917","journal-title":"Pharmaceutics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116512","article-title":"Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV","volume":"229","author":"Rodr\u00edguez-Mora S","year":"2024","unstructured":"Rodr\u00edguez-Mora S, S\u00e1nchez-Men\u00e9ndez C, Bautista-Carrascosa G, et al.. Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV. Biochem Pharmacol. 2024, 229:116512. 10.1016\/j.bcp.2024.116512","journal-title":"Biochem Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00462-5","article-title":"Tyrosine kinase inhibition: a new perspective in the fight against HIV","volume":"16","author":"Rodr\u00edguez-Mora S","year":"2019","unstructured":"Rodr\u00edguez-Mora S, Spivak AM, Szaniawski MA, L\u00f3pez-Huertas MR, Alcam\u00ed J, Planelles V, Coiras M. Tyrosine kinase inhibition: a new perspective in the fight against HIV. Curr HIV\/AIDS Rep. 2019, 16:414-22. 10.1007\/s11904-019-00462-5","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317352-hyperleukocytosis-in-a-patient-with-chronic-myeloid-leukemia-and-hiv-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T17:52:29Z","timestamp":1767462749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317352-hyperleukocytosis-in-a-patient-with-chronic-myeloid-leukemia-and-hiv-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100700","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,3]]}}}